CSIR Central

4-Anilinoquinoline triazines: A novel class of hybrid antimalarial agents

IR@CDRI: CSIR-Central Drug Research Institute, Lucknow

View Archive Info
 
 
Field Value
 
Creator Kumar, Ashok
Srivastava, Kumkum
Rajakumar, S
Siddiqi, M I
Puri, S K
Sexana, J K
Chauhan, P M S
 
Date 2011-03-18T08:22:40Z
2011-03-18T08:22:40Z
2010
 
Identifier European Journal of Medicinal Chemistry 46(2), 11, 676-690
http://hdl.handle.net/123456789/652
 
Description A novel class of hybrid 4-anilinoquinoline triazines have been synthesized and evaluated in vitro for their antimalarial activity against CQ-sensitive 3D7 strain of P. falciparum as well as for their cytotoxicity towards VERO cell line. Five compounds (19, 20, 23, 41 and 45) exhibited the antimalarial potency superior to CQ. Compounds 14 and 16 were found to be orally active at a dose of 100 mg/kg x 4 days against CQ-resistant strain of P. Yoelii. Inhibition of β-hematin formation assay and molecular docking study has been conducted in order to gain insight into the mechanism of action of proposed targets for the 4-anilinoquinoline and triazine moiety of the hybrid compounds
 
Format 562046 bytes
application/pdf
 
Language en
 
Relation CDRI Communication No 7995
 
Subject 4-Anilinoquinoline triazine
Antimalarial
P. Falciparum
P. Yoelii
 
Title 4-Anilinoquinoline triazines: A novel class of hybrid antimalarial agents
 
Type Article